103 Views | 110 Downloads
Correspondence: Stanley M. Fineman
Disclosures: Dr Fineman reports serving as a clinical investigator for Aimmune Therapeutics, Biocryst Pharmaceuticlas, Inc, DBV Technologies, and Regeneron; and as a speaker/teacher for Takeda Pharmaceutical Company Limited.
Dr Mahr reports serving as a speaker/teacher for AstraZeneca, GlaxoSmithKline, Kaleo, Inc, Optinose US, Inc, Regeneron, and Sanofi; and served as a consultant of Kaleo, Inc, Regeneron, and Sanofi.
Dr Chipps served on the advisory board and as a consultant or a speaker/teacher for Circassia, Genentech, Inc, Novartis, Regeneron, Sanofi, and Teva Pharmaceutical Industries Ltd. Dr Lee has no conflicts of interest to report.
The authors have no funding sources to report.
© 2021 Published by Elsevier Inc. on behalf of American College of Allergy, Asthma & Immunology.